The European dermal fillers market is forecast to grow at a CAGR of 6.7% during the forecast period and is estimated to reach around $1.6 billion in 2025 as compared to $994 million in 2018. Countries in the region are developed economies, which offers a significant infrastructure to provide modern technologies related to cosmetic surgeries to its citizen. High per capita disposable income in the region is also a major factor driving the growth of the market. As per Eurostat, the adjusted gross disposable income of household per capita in EU 28 is around $22,840 in 2018 as compared to nearly $20,400 in 2012.
Get Free Sample Copy @ https://www.omrglobal.com/request-sample/european-dermal-fillers-market
The high proportion of middle-age population in the region is also one of the major factors for the growth of the market. As per United Nation, around 45% of the total population in Europe is in the age range of 35-64 years in 2019, which is the highest user of dermal filler. Germany is expected to be the largest market with highest growth rate in the region. It is the largest economy in the country and among top destinations for dermal fillers globally.
Browse for Full Report Description@ https://www.omrglobal.com/industry-reports/european-dermal-fillers-market
The European dermal fillers market can be segmented on the basis of application, type, and end-users. On the basis of application, the market is classified into face-lift, lip treatment/enhancement, facial line correction, and others. Among these, facial line correction segment is expected to capture the largest market share during the forecast period. It is due to the increasing demand for reducing the effects of aging which appears on the skin. Furthermore, the face-lift application includes the treatment of temporal and forehead augmentation and facial scars, and its adoption is escalating at a considerable rate in the dermal fillers market. On the basis of end-users, the market is classified into dermatology clinics and hospitals.
Furthermore, the major market players operating in the European dermal fillers market include Allergan PLC, Merz Pharmaceuticals GmbH, Galderma Laboratories, L.P., Prollenium Medical Technologies, Inc., Cynosure LLC, and Teoxane SA. The key market players are focusing on R&D, in order to develop improved products to capture a prominent share in the market.
Market Segmentation
By Application
- Face-Lift
- Lip Treatment/Enhancement
- Facial Line Correction Treatment
- Others (Acne Scar Treatment)
By Type
- Collagen Fillers
- Ploy-L-Lactic Acid (PLLA)
- Hyaluronic Acid (HA)
- Calcium Hydroxylapatite (CaHA)
- Others (Autologous Fat Injections and Polymethylmethacrylate (PMMA))
By End-User
- Dermatology Clinics
- Hospitals
Regional Analysis
- UK
- Germany
- Italy
- Spain
- France
- Rest of Europe
Company Profiles
- Allergan PLC
- BIOHA Laboratories
- Croma-Pharma GmbH
- Cynosure LLC
- Korman Laboratories Ltd.
- Galderma Laboratories, L.P.
- MediNordic Aesthetics ApS
- Merz Pharmaceuticals GmbH
- Sculpt Luxury Dermal Fillers Ltd.
- Sinclair Pharma Ltd.
- Teoxane SA
- Vivacy Laboratories
(This release has been published on OMR Industry Journal. OMR Industry Journal is not responsible for any content included in this release.)
